Importantly, the antitumor effect was further significantly enhanced when anti-CD47 Ab-coated tumor cell vaccination was given in combination with anti-PD-1 antibody (Fig. 8b), demonstrating a synergistic effect between the two therapies. Here, CD47 is linked to neoplasm.